Crowdonomics
All companies

Max International Inc

Operating

Biotech · Salt Lake City, UT

Estimated pre-money ⓘ
$75.6M
As of Aug 2024 · from Reg CF Offering (2024) · our estimate: offering price × shares outstanding, not a stated valuation
Total raised
$65,000
Crowd $0 · Private $65K · 3 rounds since 2022
Latest share price
$10.00
Reg CF Offering (2024) offering price

Financials

FY2022–FY2023 · from SEC filings · hover any figure for its source
$25.5M
−$6.3M
2022
$14.6M
−$9.0M
2023
RevenueNet income — beside revenue when positive, below the line when a loss
Metric
FY2022 audited
FY2023 audited
Income statement
Revenue
$25,464,199
$14,603,138
Cost of goods sold
$6,394,965
$5,720,486
Gross margin
75%
61%
Net income
-$6,336,176
-$9,046,641
Taxes paid
-$15,642
$140,160
Balance sheet
Cash
$1,245,473
$1,250,868
Accounts receivable
$480,000
$421,530
Total assets
$7,865,721
$4,831,920
Short-term debt
$24,892,670
$16,636,594
Long-term debt
$561,413
$167,482
Total liabilities
$30,037,572
$16,804,076
Other
Headcount
130
100

Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.

Valuation over rounds

Pre-money — the valuation set before each round’s money came in
$63.0M
est. pre-money
$75.6M
est. pre-money
Reg A+ · Equity · Oct 2023
Reg CF · Preferred · Aug 2024

Dotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.

Cap table

Share counts as of Dec 31, 2023
Series A Preferred Stock · 9.01%Series B Preferred Stock · 1.28%Preferred stock · 10.3%Class B Common Stock · 39.7%Common stock · 39.7%
ClassOutstandingVotes / shareShare of totalVotesLiquidationDividendLast price
Series A Preferred Stockpreferred(as of Oct 24, 2023)1,361,483—9.01%6.45%paid 1st10% cumulative—
Series B Preferred Stockpreferred(as of Oct 24, 2023)193,668—1.28%0.92%paid 1st15%—
Preferred stockpreferred1,563,667—10.3%7.4%———
Class B Common Stock5,999,982239.7%56.8%———
Common stock5,999,982—39.7%28.4%———
Total15,118,782100%100%

Shares outstanding over timein today's share terms

7.6M3.8M0
Oct 2023Dec 2023
Class B Common StockCommon stockPreferred stockSeries A Preferred StockSeries B Preferred Stock

Principal holders% as the filing states it, Aug 7, 2024

  • Kevin McFarlaneClass B Common Stock70.0%of votes
  • Everyone else (not named in filings)30.0%

From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.

Fundraising history

Reg CF · Preferred Stock · Aug 2024Closedvia Issuance Express (Jumpstart Micro)
Raised $0Est. pre-money $75.6M
Reg A+ · Equity · Oct 2023Withdrawnvia DALMORE GROUP LLC
Raised $0 / $30MEst. pre-money $63M

Team

5 people
Jonathan Flicker
CEO and principal executive officer
Joseph Voyticky
CEO
James Stevralia
President
Keenyn McFarlane
CFO
Michael Szczesny
VP Operations

Names and titles as disclosed on SEC Form C, SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.

Reg CF annual-report compliance

Not obligated

never closed a Reg CF raise

Reg CF issuers must file a Form C-AR each year until a Rule 202(b) termination trigger is met.

SEC filings

  • Form C/AAug 14, 20240001644600-24-000072
    EDGAR
  • Form CAug 7, 20240001644600-24-000071
    EDGAR
  • Form 1-A-WApr 12, 20240001104659-24-046620
    EDGAR
  • Form 1-AOct 24, 20230001104659-23-111124
    EDGAR
Source: SEC EDGARCIK 0001969853UTShare price $10.00Last synced Aug 16, 2026

About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.